Canaccord Genuity Downgrades RTI Biologics (RTIX) to Hold
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Price: $3.14 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity downgraded RTI Biologics (NASDAQ: RTIX) from Buy to Hold with a price target of $4.00.
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $4.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Curaleaf announces unsolicited takeover bid for Aurora Cannabis
Create E-mail Alert Related Categories
DowngradesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
